Zhou, Yanjiao
Jackson, Daniel
Bacharier, Leonard B.
Mauger, David
Boushey, Homer
Castro, Mario
Durack, Juliana
Huang, Yvonne
Lemanske, Robert F. Jr
Storch, Gregory A.
Weinstock, George M. http://orcid.org/0000-0002-2997-4592
Wylie, Kristine
Covar, Ronina
Fitzpatrick, Anne M.
Phipatanakul, Wanda
Robison, Rachel G.
Beigelman, Avraham
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Article History
Received: 30 July 2019
Accepted: 13 November 2019
First Online: 16 December 2019
Competing interests
: D.J.: declares receiving research grants from NHLBI, NIAID, and GlaxoSmithKline. He has received personal fees for a DSMB from Pfizer, and for advisory boards from Novartis, GlaxoSmithKline, AstraZenena, Sanofi-Regeneron, Boehringer Ingelheim, and Vifor pharma. L.B.B.: declares receiving research grants from NIH, NHLBI, NIAID. He has received personal fees from GlaxoSmithKline, Genentech, Novartis, Merck, DBV technologies, Teva, Boehringer Ingelheim, Sanofi, Regeneron, AstraZenena, Vectura, Circassia. M.C.: pharmaceutical grant funding from AstraZenena, Chiesi, Novartis, GSK, Sanofi. Consultant for Genentech, Theravance, VIAA, Teva, Sanofi, Novartis. Speaker for AstraZenena, Genentech, GSK, Regeneron, Sanofi, Teva. Received royalties from Elsevier. Y.H.: research support from the NIH for microbiome research. R.F.L.: research support from the NIH for microbiome research. W.P.: Consultant for Novartis, Genentech, Regeneron, GSK, Teva, Sanofi. R.G.R.: research support from the NIH. The remaining authors declare no competing interests.